BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 10, 2011
 |  BC Week In Review  |  Company News  |  Deals

Receptos, Eli Lilly deal

Receptos and Eli Lilly will use the biotech's GPCR crystal structure determination technology to develop small molecule modulators of an undisclosed GPCR target jointly...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >